Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Cold Spring Harbor Perspectives in Medicine|December 25, 2019
Quantifying between-Host Transmission in Influenza Virus InfectionsKatherine E E Johnson, Elodie GhedinJournal of Virology|May 24, 2024
Host obesity impacts genetic variation in influenza A viral populationsMarissa Knoll, Rebekah Honce, Victoria Meliopoulos, et al.Virus Evolution|January 7, 2021
Mapping the evolutionary landscape of Zika virus infection in immunocompromised miceKatherine E E Johnson, Maria G Noval, Margarita V Rangel, et al.Mbio|October 27, 2022
Sequential Transmission of Influenza Viruses in Ferrets Does Not Enhance Infectivity and Does Not Predict Transmissibility in HumansTroy C Sutton, Elaine W Lamirande, Devanshi R Patel, et al.Journal of Virology|November 10, 2021
Structurally Conserved Domains between Flavivirus and Alphavirus Fusion Glycoproteins Contribute to Replication and Infectious-Virion ProductionMargarita V Rangel, Nicholas Catanzaro, Sara A Thannickal, et al.Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infectionsMohammed Nooruzzaman, Katherine E E Johnson, Ruchi Rani, et al.Science Advances|August 23, 2024
CD4+ and CD8+ T cells are required to prevent SARS-CoV-2 persistence in the nasal compartmentMeenakshi Kar, Katherine E E Johnson, Abigail Vanderheiden, et al.Nature Communications|September 18, 2024
Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infectionsMohammed Nooruzzaman, Katherine E E Johnson, Ruchi Rani, et al.Biorxiv : the Preprint Server for Biology|February 27, 2024
CD4+ and CD8+ T cells are required to prevent SARS-CoV-2 persistence in the nasal compartmentMeenakshi Kar, Katherine E E Johnson, Abigail Vanderheiden, et al.Journal of Virology|October 31, 2025
Tissue tropism and functional adaptation of the SARS-CoV-2 spike protein in a fatal case of COVID-19Katherine E E Johnson, Sydney Stein, Rita Afriyie Boateng, et al.Pageof 1